NextCell Pharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2019-06-28 | NextCell Pharma AB | Niclas Löwgren | Styrelseledamot/suppleant | Allotment | 20 000 | 3,25 | SEK | 65 000 | 2019-06-26 |
| 2019-06-28 | NextCell Pharma AB | Leo Cornelis Groenewegen | Business Developer | Subscription | 15 182 | 3,25 | SEK | 49 341,5 | 2019-06-27 |
| 2019-06-26 | NextCell Pharma AB | Mathias Svahn | VD | Subscription | 13 832 | 3,25 | SEK | 44 954 | 2019-06-23 |
| 2019-06-26 | NextCell Pharma AB | Mathias Svahn | VD | Subscription | 122 398 | 3,25 | SEK | 397 793,5 | 2019-06-23 |
| 2019-06-26 | NextCell Pharma AB | Mathias Svahn | VD | Subscription | 27 166 | 3,25 | SEK | 88 289,5 | 2019-06-23 |
| 2019-06-25 | NextCell Pharma AB | Anders Essen-Möller | Styrelseledamot/suppleant | Acquisition | 981 394 | 3,25 | SEK | 3 189 530,5 | 2019-06-19 |
| 2019-06-24 | NextCell Pharma AB | Anders Essen-Möller | Styrelseledamot/suppleant | Acquisition | 737 278 | 3,25 | SEK | 2 396 153,5 | 2019-06-20 |
| 2019-06-24 | NextCell Pharma AB | Hans Peter Torsten Ekre | Styrelseledamot/suppleant | Disposal | 101 645 | 0,23 | SEK | 23 378,35 | 2019-06-18 |
| 2019-06-24 | NextCell Pharma AB | Hans Peter Torsten Ekre | Styrelseledamot/suppleant | Acquisition | 7 250 | 3,25 | SEK | 23 562,5 | 2019-06-18 |
| 2019-06-20 | NextCell Pharma AB | Niclas Löwgren | Styrelseledamot/suppleant | Subscription | 112 688 | 366 236 | SEK | 41 270 402 368 | 2019-06-19 |
| 2018-08-24 | NextCell Pharma AB | Hans-Peter Ekre | Styrelseledamot/suppleant | Exercise increase | 6 120 | 5 | SEK | 30 600 | 2018-08-23 |
| 2018-08-24 | NextCell Pharma AB | Hans-Peter Ekre | Styrelseledamot/suppleant | Exercise decrease | 6 120 | 5 | SEK | 30 600 | 2018-08-23 |
| 2018-08-23 | NextCell Pharma AB | Niclas Löwgren | Styrelseledamot/suppleant | Exercise decrease | 24 000 | 0 | SEK | 0 | 2018-08-22 |
| 2018-08-23 | NextCell Pharma AB | Niclas Löwgren | Styrelseledamot/suppleant | Exercise increase | 24 000 | 5 | SEK | 120 000 | 2018-08-22 |
| 2018-08-23 | NextCell Pharma AB | BioAll AB | VD | Exercise decrease | 19 200 | 0 | SEK | 0 | 2018-08-22 |
| 2018-08-23 | NextCell Pharma AB | BioAll AB | VD | Exercise increase | 19 200 | 5 | SEK | 96 000 | 2018-08-22 |
| 2018-08-23 | NextCell Pharma AB | Leo Cornelis Groenewegen | Ekonomi/finanschef | Exercise decrease | 5 050 | 0 | SEK | 0 | 2018-08-22 |
| 2018-08-23 | NextCell Pharma AB | Leo Cornelis Groenewegen | Ekonomi/finanschef | Exercise increase | 5 050 | 5 | SEK | 25 250 | 2018-08-22 |
| 2018-08-23 | NextCell Pharma AB | Mathias Svahn | VD | Exercise increase | 20 000 | 5 | SEK | 100 000 | 2018-08-22 |
| 2018-08-23 | NextCell Pharma AB | Mathias Svahn | VD | Exercise decrease | 20 000 | 0 | SEK | 0 | 2018-08-22 |